Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Boehringer Ingelheim Investigational Site 1, Aachen

Boehringer Ingelheim Investigational Site 10, Berlin

Boehringer Ingelheim Investigational Site 11, Berlin

Boehringer Ingelheim Investigational Site 12, Berlin

Boehringer Ingelheim Investigational Site 13, Berlin

Boehringer Ingelheim Investigational Site 14, Berlin

Boehringer Ingelheim Investigational Site 15, Berlin

Boehringer Ingelheim Investigational Site 2, Berlin

Boehringer Ingelheim Investigational Site 3, Berlin

Boehringer Ingelheim Investigational Site 4, Berlin

Boehringer Ingelheim Investigational Site 5, Berlin

Boehringer Ingelheim Investigational Site 6, Berlin

Boehringer Ingelheim Investigational Site 7, Berlin

Boehringer Ingelheim Investigational Site 8, Berlin

Boehringer Ingelheim Investigational Site 9, Berlin

Boehringer Ingelheim Investigational Site 16, Bochum

Boehringer Ingelheim Investigational Site 17, Bonn

Boehringer Ingelheim Investigational Site 18, Bremen

Boehringer Ingelheim Investigational Site 19, Dortmund

Boehringer Ingelheim Investigational Site 20, Duisburg

Boehringer Ingelheim Investigational Site 21, Düsseldorf

Boehringer Ingelheim Investigational Site 22, Düsseldorf

Boehringer Ingelheim Investigational Site 23, Düsseldorf

Boehringer Ingelheim Investigational Site 24, Düsseldorf

Boehringer Ingelheim Investigational Site 25, Frankfurt

Boehringer Ingelheim Investigational Site 26, Frankfurt

Boehringer Ingelheim Investigational Site 27, Frankfurt

Boehringer Ingelheim Investigational Site 28, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 29, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 30, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 31, Hamburg

Boehringer Ingelheim Investigational Site 32, Hamburg

Boehringer Ingelheim Investigational Site 33, Hamburg

Boehringer Ingelheim Investigational Site 34, Hamburg

Boehringer Ingelheim Investigational Site 35, Hamburg

Boehringer Ingelheim Investigational Site 36, Hamburg

Boehringer Ingelheim Investigational Site 37, Hanover

Boehringer Ingelheim Investigational Site 38, Hanover

Boehringer Ingelheim Investigational Site 39, Hanover

Boehringer Ingelheim Investigational Site 40, Heidelberg

Boehringer Ingelheim Investigational Site 41, Karlsruhe

Boehringer Ingelheim Investigational Site 42, Koblenz

Boehringer Ingelheim Investigational Site 43, Leipzig

Boehringer Ingelheim Investigational Site 44, Mannheim

Boehringer Ingelheim Investigational Site 45, Mannheim

Boehringer Ingelheim Investigational Site 46, München

Boehringer Ingelheim Investigational Site 47, München

Boehringer Ingelheim Investigational Site 48, München

Boehringer Ingelheim Investigational Site 49, München

Boehringer Ingelheim Investigational Site 50, München

Boehringer Ingelheim Investigational Site 51, Münster

Boehringer Ingelheim Investigational Site 52, Münster

Boehringer Ingelheim Investigational Site 53, Münster

Boehringer Ingelheim Investigational Site 54, Oldenburg

Boehringer Ingelheim Investigational Site 55, Osnabrück

Boehringer Ingelheim Investigational Site 56, Saarbrücken

Boehringer Ingelheim Investigational Site 57, Stuttgart

Boehringer Ingelheim Investigational Site 58, Stuttgart

Boehringer Ingelheim Investigational Site 59, Stuttgart

Boehringer Ingelheim Investigational Site 60, Wuppertal